- AbbVie Announces HUMIRA® (adalimumab) Patent License with Mylan PR Newswire (press release)
- AbbVie, Mylan enter patent license agreement for biosimilar adalimumab product Healio
- AbbVie (ABBV) Granted HUMIRA (adalimumab) Patent License with Mylan (MYL) StreetInsider.com
Full coverage
|
